Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial

被引：0

作者：

Kivitz, Alan ^{[1
]}

Sedova, Liliana ^{[2
,3
]}

Churchill, Melvin ^{[4
]}

Vizcaya, Cynthia ^{[5
]}

Sutariya, Reema ^{[6
]}

Cao, Wenhao ^{[6
]}

Singhal, Atul ^{[7
]}

机构：

[1] Altoona Ctr Clin Res, Duncansville, PA USA

[2] Inst Rheumatol, Prague, Czech Republic

[3] Charles Univ Prague, Clin Rheumatol, Fac Med 1, Prague, Czech Republic

[4] Arthrit Ctr Nebraska, Lincoln, NE USA

[5] Novartis Pharma AG, Basel, Switzerland

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Southwest Arthrit Res Grp, Mesquite, TX USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2354

引用

页码：4750 / 4752

页数：3

共 50 条

[21] Post hoc subgroup analysis and the truth of a clinical trial
Adams, KF
AMERICAN HEART JOURNAL, 1998, 136 (05) : 753 - 758
[22] Secukinumab Improves Axial Manifestations in Patients with Psoriatic Arthritis and Inadequate Response to NSAIDs: Primary Analysis of Phase 3 Trial
aBraliakos, Xenofon
Coates, Laura
Gossec, Laure
Jeka, Slawomir
Mera, Antonio
Schulz, Barbara
Rissler, Michael
Das Gupta, Ayan
Perella, Chiara
Pournara, Effie
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[23] Disease Course and Complement as Predictors of Response to Standard of Care Plus Placebo in Patients with SLE: A Post Hoc Analysis of Dapirolizumab Pegol and Epratuzumab Clinical Trial Data
Stach, Christian
Gordon, Caroline
Taieb, Vanessa
Stojan, George
Merrill, Joan
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2965 - 2967
[24] Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
Palmer, Robert
Almquist, Joachim
Hashemi, Mahdi
Taib, Ziad
Necander, Sofia
Korsback, Katarina
Aurell, Malin
Asimus, Sara
Delaney, Stephen
Pardali, Katerina
Gustafson, Per
Sethi, Tariq
Keeling, David
Psallidas, Ioannis
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[25] Effect of 2016 FDA guidance on study population and clinical response rates in patients with bacterial vaginosis: a phase 3 post hoc analysis
Nyirjesy, P.
Padula, M.
Amprey, J. L.
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2019, 46 (04): : 615 - 617
[26] Effect of secukinumab on draining tunnels in patients with moderate to severe hidradenitis suppurativa: Post hoc analysis of the SUNSHINE and SUNRISE phase 3 randomized trials
Bechara, Falk G.
Becherel, Pierre-Andre
Reguiai, Ziad
Mendes-Bastos, Pedro
Kirby, Joslyn S.
Hsiao, Jennifer
Bachhuber, Teresa
Wozniak, Magdalena B.
Kasparek, Torben
Ortmann, Christine-Elke
Lobach, Iryna
Field, Clarice
Ravichandran, Shoba
Kimball, Alexa B.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 140 - 141
[27] Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc Analysis
Magrey, Marina
Ramiro, Sofi A.
Pinheiro, Marcelo Medeiros
Gao, Tianming
Ganz, Fabiana
Song, In-Ho
Biljan, Ana
Haroon, Nigil
Rudwaleit, Martin
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1931 - 1933
[28] ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB OR ADALIMUMAB: A POST HOC ANALYSIS OF EXCEED
Kaeley, G. S.
Schett, G.
Conaghan, P. G.
Mcgonagle, D.
Behrens, F.
Goupille, P.
Gaillez, C.
Parikh, B.
Meng, X.
Bakewell, C.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 311 - 312
[29] TIME TO FIRST DYSPHAGIA SYMPTOM RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
Dellon, Evan S.
Collins, Margaret H.
Katzka, David A.
Mukkada, Vincent A.
Falk, Gary W.
Goodwin, Bridgett
Wojtowicz, Abigail M.
Boules, Mena
Zhang, Wenwen
Desai, Nirav K.
Hirano, Ikuo
GASTROENTEROLOGY, 2021, 160 (06) : S249 - S250
[30] Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trial
Baraliakos, X.
Sewerin, P.
de Miguel, E.
Pournara, E.
Kleinmond, C.
Shekhawat, A.
Jentzsch, C.
Wiedon, A.
Behrens, F.
ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)

← 1 2 3 4 5 →